These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients. Morin C; Fardet L Clin Rheumatol; 2015 Dec; 34(12):2119-26. PubMed ID: 25956956 [TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids and cardiovascular risk factors. Strohmayer EA; Krakoff LR Endocrinol Metab Clin North Am; 2011 Jun; 40(2):409-17, ix. PubMed ID: 21565675 [TBL] [Abstract][Full Text] [Related]
7. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. McIntyre RS; Jerrell JM Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645 [TBL] [Abstract][Full Text] [Related]
8. The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications. Isidori AM; Graziadio C; Paragliola RM; Cozzolino A; Ambrogio AG; Colao A; Corsello SM; Pivonello R; J Hypertens; 2015 Jan; 33(1):44-60. PubMed ID: 25415766 [TBL] [Abstract][Full Text] [Related]
9. Metabolic Complications in Adrenal Insufficiency. Ueland GA; Husebye ES Front Horm Res; 2018; 49():104-113. PubMed ID: 29894991 [TBL] [Abstract][Full Text] [Related]
10. [Glucocorticoid-induced osteoporosis: recent findings]. Angeli A; Osella G; Reimondo G; Terzolo M Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891 [TBL] [Abstract][Full Text] [Related]
11. Could Exogenous Insulin Ameliorate the Metabolic Dysfunction Induced by Glucocorticoids and COVID-19? Whyte MB; Vas PRJ; Umpleby AM Front Endocrinol (Lausanne); 2021; 12():649405. PubMed ID: 34220705 [TBL] [Abstract][Full Text] [Related]
18. [Long-term consequences of polycystic ovary syndrome]. Grigoryan OR; Zhemaite NS; Volevodz NN; Andreeva EN; Melnichenko GA; Dedov II Ter Arkh; 2017; 89(10):75-79. PubMed ID: 29171475 [TBL] [Abstract][Full Text] [Related]
19. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection. Barbaro G Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Van Gaal L; Pi-Sunyer X; Després JP; McCarthy C; Scheen A Diabetes Care; 2008 Feb; 31 Suppl 2():S229-40. PubMed ID: 18227491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]